With the fall comes the announcement of multiple, prestigious, scientific awards; the first of which are those given by the ...

Investors and analysts predict the FDA will approve Applied Therapeutics' lead candidate govorestat for classic galactosemia ...

Getting more effective drugs for patients in need as quickly as possible should be the ultimate reward and objective.

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

A team tested different combinations of bacterial strains and identified a group of eighteen that suppressed ...

The interest rate cut expected this week has a potential double impact of opening financial options to emerging growth ...

T cells refueled with extra mitochondria exhibited heightened antitumor activity and reduced signs of exhaustion in ...

Research in cell cultures and mice demonstrates an antidepressant called vortioxetine may be effective in combating glioblastomas.

Researchers investigated RA51C and uncovered over 3,000 harmful genetic changes that could increase cancer risk.

Using engineered mice, researchers developed monoclonal antibodies that were effective against infection with A. baumannii.

A new bioprocessing technique developed by a team of researchers could improve a range of therapies based on CAR-T cells.

On the latest episode of the science talk show GEN Live, I was joined by a pair of experts to discuss the state of ...